This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Plexus (PLXS) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) fourth-quarter results reflect robust revenues from Healthcare/Life Sciences, Industrial/Commercial and Aerospace/Defense sectors.
Plexus (PLXS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 8.14% and 4.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Plexus (PLXS) Q4 Earnings Expected to Decline
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Down 0.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) third-quarter results benefit from robust revenues from Healthcare/Life Sciences and Aerospace/Defense sectors despite unfavorable mix, which hurt margins.
Plexus (PLXS) Q3 Earnings Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -1.22% and 2.49%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Down 6.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Plexus (PLXS) second-quarter fiscal 2019 results benefit from strong performance of Healthcare/Life Sciences and Aerospace/Defense segments.
Plexus (PLXS) Q2 Earnings Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -7.06% and 1.51%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Plexus (PLXS) Up 10.1% Since Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Beats Q1 Earnings Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) first-quarter fiscal 2019 results benefit from strong performance of the Healthcare/Life Sciences segment.
Plexus (PLXS) Tops Q1 Earnings Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 1.11% and -0.50%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus' (PLXS) fiscal fourth-quarter 2018 results benefit from strong performance of the Industrial/Commercial segment and increasing wins from the manufacturing program
Plexus (PLXS) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 10.34% and 1.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Q4 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Misses Q3 Earnings Estimates, Beats Revenues
by Zacks Equity Research
Plexus' (PLXS) fiscal third-quarter revenues benefit from strengthening Healthcare/Life Sciences revenues and increasing wins from the manufacturing program.
Why Is Plexus (PLXS) Down 5.2% Since Its Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Enters Oversold Territory
by Zacks Equity Research
Plexus Corp. (PLXS) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Plexus (PLXS) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Plexus' (PLXS) second-quarter fiscal 2018 revenues benefit from strengthening Industrial/Commercial segment and solid growth in Healthcare/Life Sciences sector.
Top Ranked Momentum Stocks to Buy for March 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 23rd:
Plexus (PLXS) Down 1.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Rides on Program Wins, Rising Investments Hurt
by Zacks Equity Research
Customer wins in the industrial and healthcare market is driving Plexus' (PLXS) top line. However, increasing investment remains an overhang.